MoonLake ImmunotherapeuticsMM

MoonLake Immunotherapeutics

54,15USDR
+1,13+2,13%
Última atualização em 2024 Dez 31, 21:00 Horário Universal (UTC)
USD
Sem negociações
Veja nos super gráficos

Fundamentos de MLTX

MoonLake Immunotherapeutics demonstrativos financeiros, incluindo receitas, despesas, lucros e perdas

O relatório anual e trimestral de resultados abaixo ajudará você a entender o desempenho de MLTX.

Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−44,00 M‬‬
‪‪−33,00 M‬‬
‪‪−22,00 M‬‬
‪‪−11,00 M‬‬
‪0,00‬
Receita Total
Lucro Bruto
Resultado Operacional
Receita antes de impostos
Lucro Líquido
Moeda: USD
Q3 '20
Set 2020
Q4 '20
Dez 2020
Q1 '21
Маr 2021
Q2 '21
Jun 2021
Q3 '21
Set 2021
Q4 '21
Dez 2021
Q1 '22
Маr 2022
Q2 '22
Jun 2022
Q3 '22
Set 2022
Q4 '22
Dez 2022
Q1 '23
Маr 2023
Q2 '23
Jun 2023
Q3 '23
Set 2023
Q4 '23
Dez 2023
Q1 '24
Маr 2024
Q2 '24
Jun 2024
Q3 '24
Set 2024
TTM
Receita TotalCrescimento Ano a Ano
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
‪‪−22,81 K‬‬
‪‪−28,11 K‬‬
‪‪−32,52 K‬‬
‪‪−86,73 K‬‬
Lucro BrutoCrescimento Ano a Ano
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
‪‪−3,29 K‬‬
+0,09%
‪‪−3,29 K‬‬
0,00%
‪‪−22,81 K‬‬
−593,40%
‪‪−28,11 K‬‬
−754,73%
‪‪−32,52 K‬‬
−888,30%
‪‪−86,73 K‬‬
‪‪−16,69 M‬‬
‪‪−12,93 M‬‬
‪‪−13,18 M‬‬
‪‪−12,97 M‬‬
‪‪−15,03 M‬‬
‪‪−19,80 M‬‬
‪‪−30,55 M‬‬
‪‪−43,08 M‬‬
‪‪−108,45 M‬‬
Resultado OperacionalCrescimento Ano a Ano
‪‪−16,70 M‬‬
−650,65%
‪‪−12,93 M‬‬
−376,92%
‪‪−13,19 M‬‬
+25,30%
‪‪−12,98 M‬‬
+12,14%
‪‪−15,03 M‬‬
+9,99%
‪‪−19,82 M‬‬
−53,27%
‪‪−30,58 M‬‬
−131,90%
‪‪−43,11 M‬‬
−232,23%
‪‪−108,54 M‬‬
‪‪239,50 K‬‬
‪‪723,59 K‬‬
‪‪842,65 K‬‬
‪‪1,39 M‬‬
‪‪7,19 M‬‬
‪‪5,92 M‬‬
‪‪5,90 M‬‬
‪‪7,09 M‬‬
‪‪26,09 M‬‬
Receita antes de impostosCrescimento Ano a Ano
‪‪−16,46 M‬‬
−640,63%
‪‪−12,21 M‬‬
−351,53%
‪‪−12,34 M‬‬
+29,09%
‪‪−11,59 M‬‬
+21,33%
‪‪−7,84 M‬‬
+52,34%
‪‪−13,91 M‬‬
−13,90%
‪‪−24,68 M‬‬
−99,95%
‪‪−36,02 M‬‬
−210,79%
‪‪−82,45 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−11,01 K‬‬
‪‪−11,01 K‬‬
‪‪−10,15 K‬‬
‪‪−28,92 K‬‬
‪‪−44,31 K‬‬
‪‪−70,25 K‬‬
‪‪−78,70 K‬‬
‪‪−92,11 K‬‬
‪‪−285,37 K‬‬
‪‪4,61 M‬‬
‪‪3,21 M‬‬
‪‪2,21 M‬‬
‪‪2,19 M‬‬
‪‪450,31 K‬‬
‪‪301,87 K‬‬
‪‪491,74 K‬‬
‪‪724,09 K‬‬
‪‪1,97 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−11,86 M‬‬
‪‪−9,00 M‬‬
‪‪−10,14 M‬‬
‪‪−9,43 M‬‬
‪‪−7,44 M‬‬
‪‪−13,67 M‬‬
‪‪−24,27 M‬‬
‪‪−35,39 M‬‬
‪‪−80,77 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Lucro LíquidoCrescimento Ano a Ano
‪‪−11,86 M‬‬
−433,84%
‪‪−9,00 M‬‬
−233,05%
‪‪−10,14 M‬‬
+16,35%
‪‪−9,43 M‬‬
+6,77%
‪‪−7,44 M‬‬
+37,30%
‪‪−13,67 M‬‬
−51,85%
‪‪−24,27 M‬‬
−139,34%
‪‪−35,39 M‬‬
−275,45%
‪‪−80,77 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−11,86 M‬‬
‪‪−9,00 M‬‬
‪‪−10,14 M‬‬
‪‪−9,43 M‬‬
‪‪−7,44 M‬‬
‪‪−13,67 M‬‬
‪‪−24,27 M‬‬
‪‪−35,39 M‬‬
‪‪−80,77 M‬‬
‪−0,31‬
−103,46%
‪−0,23‬
−25,75%
‪−0,23‬
+32,65%
‪−0,18‬
+35,68%
‪−0,12‬
+59,36%
‪−0,22‬
+5,29%
‪−0,39‬
−66,45%
‪−0,56‬
−219,53%
‪−1,29‬
‪−0,31‬
−103,46%
‪−0,23‬
−25,75%
‪−0,23‬
+32,65%
‪−0,18‬
+35,68%
‪−0,12‬
+59,36%
‪−0,22‬
+5,29%
‪−0,39‬
−66,45%
‪−0,56‬
−219,53%
‪−1,29‬
‪‪38,84 M‬‬
‪‪39,06 M‬‬
‪‪43,72 M‬‬
‪‪53,52 M‬‬
‪‪59,91 M‬‬
‪‪62,64 M‬‬
‪‪62,87 M‬‬
‪‪62,90 M‬‬
‪‪38,84 M‬‬
‪‪39,06 M‬‬
‪‪43,72 M‬‬
‪‪53,52 M‬‬
‪‪59,91 M‬‬
‪‪62,64 M‬‬
‪‪62,87 M‬‬
‪‪62,90 M‬‬
EBITDACrescimento Ano a Ano
‪‪−16,69 M‬‬
−650,50%
‪‪−12,93 M‬‬
−376,79%
‪‪−13,18 M‬‬
+25,32%
‪‪−12,97 M‬‬
+12,15%
‪‪−15,03 M‬‬
+9,99%
‪‪−19,80 M‬‬
−53,13%
‪‪−30,55 M‬‬
−131,75%
‪‪−43,08 M‬‬
−232,06%
‪‪−108,45 M‬‬
EBITCrescimento Ano a Ano
‪‪−16,70 M‬‬
−650,65%
‪‪−12,93 M‬‬
−376,92%
‪‪−13,19 M‬‬
+25,30%
‪‪−12,98 M‬‬
+12,14%
‪‪−15,03 M‬‬
+9,99%
‪‪−19,82 M‬‬
−53,27%
‪‪−30,58 M‬‬
−131,90%
‪‪−43,11 M‬‬
−232,23%
‪‪−108,54 M‬‬
‪‪−16,70 M‬‬
‪‪−12,93 M‬‬
‪‪−13,19 M‬‬
‪‪−12,98 M‬‬
‪‪−15,03 M‬‬
‪‪−19,82 M‬‬
‪‪−30,58 M‬‬
‪‪−43,11 M‬‬
‪‪−108,54 M‬‬